Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 67.94 CNY -0.83% Market Closed
Market Cap: 50.4B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Hangzhou Tigermed Consulting Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hangzhou Tigermed Consulting Co Ltd
Operating Income Peer Comparison

Comparables:
603259
300759
2269
M
688114
W
2268

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
ÂĄ1.5B
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
30%
WuXi AppTec Co Ltd
SSE:603259
Operating Income
ÂĄ10.6B
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
ÂĄ1.6B
CAGR 3-Years
5%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
ÂĄ3.9B
CAGR 3-Years
10%
CAGR 5-Years
34%
CAGR 10-Years
N/A
M
MGI Tech Co Ltd
SSE:688114
Operating Income
-ÂĄ742.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Operating Income
ÂĄ410.8m
CAGR 3-Years
127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hangzhou Tigermed Consulting Co Ltd's Operating Income?
Operating Income
1.5B CNY

Based on the financial report for Jun 30, 2024, Hangzhou Tigermed Consulting Co Ltd's Operating Income amounts to 1.5B CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
30%

Over the last year, the Operating Income growth was -15%. The average annual Operating Income growth rates for Hangzhou Tigermed Consulting Co Ltd have been 13% over the past three years , 20% over the past five years , and 30% over the past ten years .

Back to Top